weight regain after stopping glp-1 agonists Ozempic, Wegovy & Mounjaro: What to Know GLP-1 therapies are changing obesity
Description
Clinical implication Considering the potential for gastric food retention and aspiration risks associated with surgical or endoscopic interventions, the American Society of Anesthesiologists recommends the discontinuation of short-acting GLP-1 RAs one day and long-acting formulations at least 1 week before surgical procedures [27]
Available from: www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss [Last accessed: December 31, 2023]
R., Shelburne J
What is the difference between semaglutide and tirzepatide
We focus on combining safe, effective medication with a realistic lifestyle plan
